Literature DB >> 28662582

Further New Gypenosides from Jiaogulan (Gynostemma pentaphyllum).

Jun Wang1,2, Jun-Li Yang1, Pan-Pan Zhou3, Xian-Hua Meng1, Yan-Ping Shi1.   

Abstract

Jiaogulan (Gynostemma pentaphyllum) has been widely used as a herbal tea, dietary supplement, and vegetable in Asian countries. In this study, six new gypenosides (1-6) were isolated from the aerial parts of G. pentaphyllum. Their molecular structures were elucidated through spectroscopic analysis and acid hydrolysis. Gypenosides 1 and 2 represented the first example of a dammar-21-O- glucopyranoside without any unsaturated functional group and a dammar-3-O-glucopyranosyl-25-O-glucopyranoside without any cyclization in the side chain, respectively. In addition, gypenosides 5 and 6 exhibited the first example of a 24-hydroperoxy-19-oxo-dammarane triterpenoid and 19-oxo-dammar-21-O-glucopyranoside with a saturated side chain, respectively. Gypenoside 5 was found to possess protein tyrosine phosphatase 1B inhibitory activity, with an IC50 value of 8.2 ± 0.9 μM, and moderate cytotoxicity against human breast cancer cells MCF7, MCF7/ADR, and MDA-MB-231, with IC50 values ranging from 10.5 ± 1.4 to 14.2 ± 2.6 μM. The outcome of the study provided crucial information regarding the structural diversity and health benefits of gypenosides.

Entities:  

Keywords:  Gynostemma pentaphyllum; PTP1B inhibitory activity; cytotoxicity; jiaogulan; new gypenosides

Mesh:

Substances:

Year:  2017        PMID: 28662582     DOI: 10.1021/acs.jafc.7b01477

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  11 in total

1.  Anticancer Activity of Polysaccharides Produced from Glycerol and Crude Glycerol by an Endophytic Fungus Chaetomium globosum CGMCC 6882 on Human Lung Cancer A549 Cells.

Authors:  Zichao Wang; Peizhang Chen; Ning Tao; Huiru Zhang; Ruifang Li; Xiaobei Zhan; Fuzhuan Wang; Yingben Shen
Journal:  Biomolecules       Date:  2018-12-11

2.  Gynostemma Pentaphyllum Extract Ameliorates High-Fat Diet-Induced Obesity in C57BL/6N Mice by Upregulating SIRT1.

Authors:  Hyun Sook Lee; Su-Min Lim; Jae In Jung; So Mi Kim; Jae Kyoung Lee; Yoon Hee Kim; Kyu Min Cha; Tae Kyu Oh; Joo Myung Moon; Tae Young Kim; Eun Ji Kim
Journal:  Nutrients       Date:  2019-10-15       Impact factor: 5.717

3.  Diterpenoid Alkaloids and One Lignan from the Roots of Aconitum pendulum Busch.

Authors:  Jun Wang; Xian-Hua Meng; Tian Chai; Jun-Li Yang; Yan-Ping Shi
Journal:  Nat Prod Bioprospect       Date:  2019-11-14

Review 4.  Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants.

Authors:  Gerardo Mata-Torres; Adolfo Andrade-Cetto; Fernanda Espinoza-Hernández
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

5.  Activity Components from Gynostemma pentaphyllum for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach.

Authors:  Yumeng Zhang; Guohui Shi; Zhonghua Luo; Jiewen Wang; Shao Wu; Xiaoshu Zhang; Yuqing Zhao
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

6.  Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet.

Authors:  Yanliu Lu; Yimei Du; Lin Qin; Di Wu; Wei Wang; Lei Ling; Feifei Ma; Hua Ling; Li Yang; Changhong Wang; Zhengtao Wang; Xumei Zhou; Yuqi He
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-12       Impact factor: 2.629

7.  Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.

Authors:  Hongshan Li; Yingfei Xi; Xin Xin; Huajie Tian; Yiyang Hu
Journal:  Nutr Metab (Lond)       Date:  2020-05-01       Impact factor: 4.169

8.  Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).

Authors:  Jin Ha Lee; Ji Young Oh; Soo Hyun Kim; In Jeong Oh; Yong-Ho Lee; Keun Woo Lee; Woong Hee Lee; Jeong-Hwan Kim
Journal:  Biomolecules       Date:  2020-10-08

9.  Gene excavation and expression analysis of CYP and UGT related to the post modifying stage of gypenoside biosynthesis in Gynostemma pentaphyllum (Thunb.) Makino by comprehensive analysis of RNA and proteome sequencing.

Authors:  Yangmei Zhang; Qicong Chen; Yuanheng Huang; Ruiqiang Zhao; Jian Sun; Xidong Yuan; Huiming Xu; Huiyu Liu; Yaosheng Wu
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

10.  Gynostemma pentaphyllum extract and Gypenoside L enhance skeletal muscle differentiation and mitochondrial metabolism by activating the PGC-1α pathway in C2C12 myotubes.

Authors:  Yoon Hee Kim; Jae In Jung; Young Eun Jeon; So Mi Kim; Tae Kyu Oh; Jaesun Lee; Joo Myung Moon; Tae Young Kim; Eun Ji Kim
Journal:  Nutr Res Pract       Date:  2021-06-29       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.